SCHEMBL216242

SCHEMBL216242

COc1ccc2nc(N)[nH]c2c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.63
TP53 P04637 4/20 0.63
HPGD P15428 3/20 0.63
ALDH1A1 P00352 3/20 0.63
SMN1; SMN2 Q16637 3/20 0.63
MEN1 O00255 2/20 0.63
POLB P06746 2/20 0.63
PKM P14618 2/20 0.63
KMT2A Q03164 2/20 0.63
LMNA P02545 1/20 0.63
TYMS P04818 1/20 0.60
RAB9A P51151 4/20 0.58
HTT P42858 1/20 0.58
KDM4E B2RXH2 1/20 0.58
TSHR P16473 1/20 0.58
NFKB1 P19838 1/20 0.58
NFKB2 Q00653 1/20 0.58
RELA Q04206 1/20 0.58
HSD17B10 Q99714 1/20 0.58
CYP1A2 P05177 6/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30174540 1.00 NPC1 (0.63) NPC1TP53HPGDALDH1A1SMN1; SMN2
Hydrochloric Acid SCHEMBL25169249 0.98 NPC1 (0.61) NPC1TP53HPGDALDH1A1SMN1; SMN2
SCHEMBL2163036 0.86 TYMS (0.52) NPC1TP53HPGDALDH1A1SMN1; SMN2
Bromide SCHEMBL17747821 0.84 TYMS (0.51) NPC1TP53HPGDALDH1A1SMN1; SMN2
SCHEMBL10966414 0.81 TYMS (0.63) NPC1TP53HPGDALDH1A1SMN1; SMN2
SCHEMBL10833674 0.81 PLAU (0.51) NPC1TP53HPGDALDH1A1SMN1; SMN2
SCHEMBL29439014 0.80 KDM4E (0.61) NPC1TP53HPGDALDH1A1SMN1; SMN2
SCHEMBL4371528 0.80 KDM4E (0.61) NPC1TP53HPGDALDH1A1SMN1; SMN2
Hydrochloric Acid SCHEMBL7240766 0.79 CBFB (0.51) NPC1TP53HPGDALDH1A1SMN1; SMN2
SCHEMBL9304583 0.79 NPC1 (0.58) NPC1TP53HPGDALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10292390-B2 Inhibition and dispersion of bacterial biofilms with 2-aminobenzimidazole derivatives WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2019-05-21 US claimed
CN-105384693-B Compound, its synthetic method and the purposes of the structure of bisazo containing benzoxazole ring 盐城工学院 2018-11-09 CN claimed
CN-105384693-A Compound containing benzoxazole ring bis(azo) structure, synthetic method for compound and use of compound YANCHENG INST TECHNOLOGY 2016-03-09 CN claimed
US-20130136782-A1 Inhibition and Dispersion of Bacterial Biofilms with 2-Aminobenzimidazole Derivatives WISCONSIN ALUMNI RESEARCH FOUNDATION 2013-05-30 US claimed
US-4496727-A ORGANIC PIGMENTS; PLASTICS; LACQUERS; INKS; COATINGS; COLOR FASTNESS CIBA-GEIGY CORPORATION (US) 1985-01-29 US claimed
US-4385174-A FOR PIGMENTS CIBA-GEIGY CORPORATION (US) 1983-05-24 US claimed
US-4349671-A Process for the production of metal complexes of isoindoline azines CIBA-GEIGY CORPORATION (US) 1982-09-14 US claimed
US-20250066411-A1 GLYCOMIMETIC BINDERS FOR L-SIGN UNIVERSITA’ DEGLI STUDI DI MILANO (IT) 2025-02-27 US disclosed
CN-114423763-B Regioselective synthesis of imidazo [1,2-a ] pyrimidines 豪夫迈·罗氏有限公司 2025-01-21 CN disclosed
US-20240182454-A1 Polycyclic Compound for Inhibiting RNA Helicase DHX33, and Application of Compound SHENZHEN KEYE LIFE TECHNOLOGIES, CO., LTD (CN) 2024-06-06 US disclosed
EP-4378940-A1 POLYCYCLIC COMPOUND FOR INHIBITING RNA HELICASE DHX33, AND APPLICATION OF COMPOUND Shenzhen Keye Life Technologies, Co., Ltd. (CN) 2024-06-05 EP disclosed
CN-114989096-B Thioazole compound and preparation method and application thereof 赣南师范大学 2023-10-24 CN disclosed
US-20230210966-A1 EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES WITH POTASSIUM CHANNEL AGONISTS AND THERAPEUTIC USES THEREOF LION BIOTECHNOLOGIES, INC. 2023-07-06 US disclosed
US-4237292-A SHADES OF YELLOW TO RED FOR PLASTICS AND LACQUERS CIBA-GEIGY CORPORATION (US) 1980-12-02 US disclosed
US-4237286-A COLORING PLASTICS AND LACQUERS IN YELLOW TO RED SHADES CIBA-GEIGY CORPORATION (US) 1980-12-02 US disclosed
US-4237293-A COLORFAST SHADES OF YELLOW TO RED FOR PLASTICS AND LACQUERS CIBA-GEIGY CORPORATION (US) 1980-12-02 US disclosed
US-4132708-A Metal complexes of azomethines and process for their manufacture CIBA-GEIGY CORPORATION (US) 1979-01-02 US disclosed
US-4111947-A DYES, PLASTICS, LACQUERS CIBA-GEIGY CORPORATION (US) 1978-09-05 US disclosed
US-4065462-A ORGANIC PIGMENTS CIBA-GEIGY CORPORATION (US) 1977-12-27 US disclosed
US-4022770-A COLORING CIBA-GEIGY CORPORATION (US) 1977-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230210966-A1 EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES WITH POTASSIUM CHANNEL AGONISTS AND THERAPEUTIC USES THEREOF KCNN3, KCNK3, KCNA3 NPC1 1119/4885TP53 389/4885HPGD 3091/4885
US-20130136782-A1 Inhibition and Dispersion of Bacterial Biofilms with 2-Aminobenzimidazole Derivatives FLNB, BRI3BP, CCNI NPC1 4849/4885TP53 3199/4885HPGD 1588/4885
US-10292390-B2 Inhibition and dispersion of bacterial biofilms with 2-aminobenzimidazole derivatives FLNB, BRI3BP, CCNI NPC1 4849/4885TP53 3199/4885HPGD 1588/4885
US-20250066411-A1 GLYCOMIMETIC BINDERS FOR L-SIGN HAVCR2, SIGLEC9, SIGLEC7 NPC1 2196/4885TP53 140/4885HPGD 4464/4885
US-20240182454-A1 Polycyclic Compound for Inhibiting RNA Helicase DHX33, and Application of Compound DHX36, DDX3X, DDX21 NPC1 825/4885TP53 959/4885HPGD 1285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.